首页> 美国卫生研究院文献>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America >The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress
【2h】

The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress

机译:抗菌素耐药性领导小组:进度报告和正在进行的工作

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Antibacterial Resistance Leadership Group (ARLG), with funding from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, was created in June 2013. Its mission is to develop, prioritize, and implement a clinical research agenda that addresses the public health threat of antibacterial resistance. This article reports on the progress that the ARLG has made to date in fulfilling its mission. Since inception, the ARLG has received and reviewed >70 study proposals, initiated >30 studies, executed >300 agreements, included data from >7000 subjects, published >45 manuscripts, and provided opportunities for 26 mentees. Despite this substantial progress, there remains significant work to be accomplished. This article also describes the considerable challenges that lie ahead.
机译:抗菌素耐药性领导小组(ARLG)由美国国立卫生研究院国家过敏和传染病研究所提供资金,于2013年6月成立。其任务是制定,确定优先次序并实施一项针对临床研究的议程。公共卫生威胁着抗菌素的抵抗。本文报告了ARLG迄今为止在履行其使命方面所取得的进展。自成立以来,ARLG已收到并审查了70多个研究计划,启动了30多个研究,执行了300多个协议,包括了7000多个主题的数据,出版了45多个手稿,并为26位受训者提供了机会。尽管取得了重大进展,但仍有大量工作要做。本文还描述了未来的巨大挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号